Repligen (NASDAQ:RGEN) Lowered to “Sell” Rating by StockNews.com
StockNews.com cut shares of Repligen (NASDAQ:RGEN – Free Report) from a hold rating to a sell rating in a research report sent to investors on Thursday. A number of other analysts have also weighed in on RGEN. Evercore ISI started coverage on Repligen in a research note on Tuesday, March 18th. They issued an “in-line” […]
StockNews.com cut shares of Repligen (NASDAQ:RGEN – Free Report) from a hold rating to a sell rating in a research report sent to investors on Thursday. A number of other analysts have also weighed in on RGEN. Evercore ISI started coverage on Repligen in a research note on Tuesday, March 18th. They issued an “in-line” […]
